Latest total revenue for APLT: $1M, below the Healthcare sector average of $110B.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2025
Trailing 12 months ending Sep 2025
As of the most recent data (September 2025), APLT shows a total revenue of $1M. That compares with $-210K in the prior-year period — up 573.5% year over year. That is below the Healthcare sector average of $110B. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, APLT's total revenue is now $1M (was $-210K) — a 573.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Applied Therapeutics is outperforming or lagging.
The Healthcare sector average total revenue is about $110B. Applied Therapeutics is at $1M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how APLT stacks up against individual peers as well.
Tracking APLT's total revenue over time shows whether Applied Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $1M That compares with $-210K in the prior-year period — up 573.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total revenue page, Stockcircle has Applied Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total revenue (currently $1M) with ownership activity and broader fundamentals.